Skip to main content
. Author manuscript; available in PMC: 2023 Nov 4.
Published in final edited form as: Cancer Discov. 2023 May 4;13(5):1084–1099. doi: 10.1158/2159-8290.CD-23-0208

Table 1.

Opportunities for accelerating declines in in cancer death rates in the U.S.

Cancer Type Outcome Potential intervention type Opportunity?
All Cancers Incidence Modifiable risk factors Reduce smoking, obesity, physical inactivity & alcohol consumption
Lung Incidence Modifiable risk factors Increase smoking cessation; prevent initiation
Mortality Screening (Early detection) Increase low-dose CT uptake and reduce disparities in use
Treatment Reduce disparities in access to more effective treatments (targeted and immune-based therapies for NSCLC)
Colorectal Incidence Screening (Prevention) Increase uptake of colonoscopy, flexible sigmoidoscopy, and FIT/FIT-DNA for hard-to-reach populations
Preventive treatment Increase adherence to diagnostic follow-up and polyp removal
Mortality Screening (Early detection) Increase uptake of colonoscopy, flexible sigmoidoscopy; gFOBT and FIT with diagnostic follow-up
Pancreas Mortality Treatment Develop and evaluate new mutant KRAS inhibitors
Breast Incidence Preventive treatment Evaluate efficacy of low-dose hormone therapies & improve risk-stratification
Mortality Modifiable risk factors post-diagnosis Evaluate strategies for increasing physical activity and decreasing obesity in survivors
Screening (Early detection) Increase mammography uptake amongst under-served populations
Treatment Increase uptake/adherence to hormone therapy and chemotherapy especially in under-served populations
Prostate Mortality Screening (Early detection) Evaluate risk-stratified PSA screening & improved diagnostic testing
Treatment Evaluate strategies to further reduce over treatment and reduce disparities
Liver Incidence Modifiable risk factors Increase uptake of HBV and HCV treatments, decrease smoking prevalence
Mortality Screening (Early detection) Increase cirrhosis diagnosis and screening uptake